Literature DB >> 31330542

Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey.

Colin W O'Brien1, Stephen P Juraschek2, Christina C Wee2.   

Abstract

Entities:  

Year:  2019        PMID： 31330542      PMCID： PMC7251544          DOI： 10.7326/M19-0953

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus.

Authors:  Davide Capodanno; Dominick J Angiolillo
Journal:  Circulation       Date:  2016-10-11       Impact factor: 29.690

2.  Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.

Authors:  Louise Bowman; Marion Mafham; Karl Wallendszus; Will Stevens; Georgina Buck; Jill Barton; Kevin Murphy; Theingi Aung; Richard Haynes; Jolyon Cox; Aleksandra Murawska; Allen Young; Michael Lay; Fang Chen; Emily Sammons; Emma Waters; Amanda Adler; Jonathan Bodansky; Andrew Farmer; Roger McPherson; Andrew Neil; David Simpson; Richard Peto; Colin Baigent; Rory Collins; Sarah Parish; Jane Armitage
Journal:  N Engl J Med       Date:  2018-08-26       Impact factor: 91.245

3.  Effect of Aspirin on Disability-free Survival in the Healthy Elderly.

Authors:  John J McNeil; Robyn L Woods; Mark R Nelson; Christopher M Reid; Brenda Kirpach; Rory Wolfe; Elsdon Storey; Raj C Shah; Jessica E Lockery; Andrew M Tonkin; Anne B Newman; Jeff D Williamson; Karen L Margolis; Michael E Ernst; Walter P Abhayaratna; Nigel Stocks; Sharyn M Fitzgerald; Suzanne G Orchard; Ruth E Trevaks; Lawrence J Beilin; Geoffrey A Donnan; Peter Gibbs; Colin I Johnston; Joanne Ryan; Barbara Radziszewska; Richard Grimm; Anne M Murray
Journal:  N Engl J Med       Date:  2018-09-16       Impact factor: 91.245

Review 4.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

5.  Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.

Authors:  J Michael Gaziano; Carlos Brotons; Rosa Coppolecchia; Claudio Cricelli; Harald Darius; Philip B Gorelick; George Howard; Thomas A Pearson; Peter M Rothwell; Luis Miguel Ruilope; Michal Tendera; Gianni Tognoni
Journal:  Lancet       Date:  2018-08-26       Impact factor: 79.321
  5 in total
  26 in total

1. 

Authors:  Theodore Wein; M Patrice Lindsay; David J Gladstone; Alexandre Poppe; Alan Bell; Leanne K Casaubon; Norine Foley; Shelagh B Coutts; Jafna Cox; James Douketis; Thalia Field; Laura Gioia; Jeffrey Habert; Eddy Lang; Shamir R Mehta; Christine Papoushek; William Semchuk; Mikul Sharma; Jacob A Udell; Stephanie Lawrence; Anita Mountain; Gord Gubitz; Dar Dowlatshahi; Anne Simard; Andrea de Jong; Eric E Smith
Journal:  CMAJ       Date:  2020-10-05       Impact factor: 8.262

2.  Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events.

Authors:  Theodore Wein; M Patrice Lindsay; David J Gladstone; Alexandre Poppe; Alan Bell; Leanne K Casaubon; Norine Foley; Shelagh B Coutts; Jafna Cox; James Douketis; Thalia Field; Laura Gioia; Jeffrey Habert; Eddy Lang; Shamir R Mehta; Christine Papoushek; William Semchuk; Mikul Sharma; Jacob A Udell; Stephanie Lawrence; Anita Mountain; Gord Gubitz; Dar Dowlatshahi; Anne Simard; Andrea de Jong; Eric E Smith
Journal:  CMAJ       Date:  2020-03-23       Impact factor: 8.262

Review 3.  Aspirin, Statins, and Primary Prevention: Opportunities for Shared Decision Making in the Face of Uncertainty.

Authors:  Amit Jhaveri; Rachel A Sibley; Erica S Spatz; John Dodson
Journal:  Curr Cardiol Rep       Date:  2021-05-07       Impact factor: 2.931

4.  Identification of undocumented over-the-counter medications in an academic nephrology clinic.

Authors:  Alex N Kokaly; Jacob E Kurlander; Kim Pais; Crystal Lee; Jordan K Schaefer; Michael Heung; Sarah E Vordenberg
Journal:  J Am Pharm Assoc (2003)       Date:  2020-08-25

Review 5.  Effect of low-dose aspirin on health outcomes: An umbrella review of systematic reviews and meta-analyses.

Authors:  Nicola Veronese; Jacopo Demurtas; Trevor Thompson; Marco Solmi; Gabriella Pesolillo; Stefano Celotto; Tommaso Barnini; Brendon Stubbs; Stefania Maggi; Alberto Pilotto; Graziano Onder; Evropi Theodoratou; Alberto Vaona; Joseph Firth; Lee Smith; Ai Koyanagi; John P A Ioannidis; Ioanna Tzoulaki
Journal:  Br J Clin Pharmacol       Date:  2020-06-02       Impact factor: 4.335

6.  Aspirin Use and Awareness for Cardiovascular Disease Prevention Among Hispanics: Prevalence and Associations with Health Behavior Beliefs.

Authors:  Jeffrey R Misialek; Jeremy R Van't Hof; Niki C Oldenburg; Clarence Jones; Milton Eder; Russell V Luepker; Sue Duval
Journal:  J Community Health       Date:  2020-08

7.  Aspirin Use and Misuse for the Primary Prevention of Cardiovascular Diseases.

Authors:  Russell V Luepker; Niki C Oldenburg; Jeffrey R Misialek; Jeremy R Van't Hof; John R Finnegan; Milton Eder; Sue Duval
Journal:  Am J Prev Med       Date:  2021-02-03       Impact factor: 5.043

Review 8.  Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients?

Authors:  Federico Cacciapuoti; Fulvio Cacciapuoti
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

9.  Survey and Analysis of Age and Antiplatelet/Anticoagulation Medication Status of the Desert Regional Medical Center Emergency Department Patients.

Authors:  Chao Li; Yasir R Khan; Javed Siddiqi
Journal:  Cureus       Date:  2021-06-15

10.  Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998-2018.

Authors:  Mikkel B Christensen; Espen Jimenez-Solem; Martin T Ernst; Morten Schmidt; Anton Pottegård; Erik L Grove
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.